1. Home
  2. NAMSW vs VFSWW Comparison

NAMSW vs VFSWW Comparison

Compare NAMSW & VFSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • VFSWW
  • Stock Information
  • Founded
  • NAMSW N/A
  • VFSWW N/A
  • Country
  • NAMSW Netherlands
  • VFSWW Singapore
  • Employees
  • NAMSW 29
  • VFSWW 13953
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • VFSWW
  • Sector
  • NAMSW Health Care
  • VFSWW
  • Exchange
  • NAMSW Nasdaq
  • VFSWW Nasdaq
  • Market Cap
  • NAMSW N/A
  • VFSWW N/A
  • IPO Year
  • NAMSW N/A
  • VFSWW N/A
  • Fundamental
  • Price
  • NAMSW $8.90
  • VFSWW $0.54
  • Analyst Decision
  • NAMSW
  • VFSWW
  • Analyst Count
  • NAMSW 0
  • VFSWW 0
  • Target Price
  • NAMSW N/A
  • VFSWW N/A
  • AVG Volume (30 Days)
  • NAMSW N/A
  • VFSWW N/A
  • Earning Date
  • NAMSW N/A
  • VFSWW N/A
  • Dividend Yield
  • NAMSW N/A
  • VFSWW N/A
  • EPS Growth
  • NAMSW N/A
  • VFSWW N/A
  • EPS
  • NAMSW N/A
  • VFSWW N/A
  • Revenue
  • NAMSW N/A
  • VFSWW N/A
  • Revenue This Year
  • NAMSW N/A
  • VFSWW N/A
  • Revenue Next Year
  • NAMSW N/A
  • VFSWW N/A
  • P/E Ratio
  • NAMSW N/A
  • VFSWW N/A
  • Revenue Growth
  • NAMSW N/A
  • VFSWW N/A
  • 52 Week Low
  • NAMSW N/A
  • VFSWW N/A
  • 52 Week High
  • NAMSW N/A
  • VFSWW N/A
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 46.37
  • VFSWW 51.78
  • Support Level
  • NAMSW $8.30
  • VFSWW $0.46
  • Resistance Level
  • NAMSW $9.77
  • VFSWW $0.60
  • Average True Range (ATR)
  • NAMSW 0.27
  • VFSWW 0.06
  • MACD
  • NAMSW -0.10
  • VFSWW 0.00
  • Stochastic Oscillator
  • NAMSW 28.57
  • VFSWW 57.14

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About VFSWW VinFast Auto Ltd. Warrant

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Automobiles, E-scooter, Spare parts & Aftermarket services. The Automobiles segment includes the design, development, manufacturing, and sales of cars and electric buses; The E-scooter segment includes the design, development, manufacturing, and sales of e-scooters; the Spare parts & Aftermarket services segment includes the sales of spare parts and rendering of aftermarket services for automobiles and e-scooters.

Share on Social Networks: